Product Information

LOTREL 5-10 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.5553 per EA under NDC 00078040505. Its NADAC has been published 388 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the amlodipine besylate and benazepril hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LOTREL 5-10 MG CAPSULE

amlodipine besylate and benazepril hydrochloride
$11.5553per EA
High Outlier

Strength

5; 10 mg/1; mg/1

NDC

00078040505

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

11/19/2025

Approval Type

New Drug (NDA)

FDA Application

NDA020364

On Market Since

3/3/1995

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Decreased Blood Pressure
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for LOTREL 5-10 MG CAPSULE has been published 388 times since Nov 28, 2013, and over the history we have for it it has risen 137.7%. The table below summarizes its recorded NADAC range and movement.

Current price$11.5553 per EA
All-time high$11.5607 (Oct 15, 2025)
All-time low$4.8623 (Nov 28, 2013)
52-week high$11.5607
52-week low$11.5553
Median price$8.4947
Average price$8.2986
Largest weekly change+22.3% (Mar 19, 2025)
Weeks tracked388
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.0%

3Y

+22.3%

5Y

+22.3%

All

+137.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the amlodipine besylate and benazepril hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of LOTREL 5-10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LOTREL 5-10 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $11.5553 per EA (NDC 00078040505), effective Jun 24, 2026.

How has the price of LOTREL 5-10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LOTREL 5-10 MG CAPSULE has risen 137.7%. It has been tracked across 388 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LOTREL 5-10 MG CAPSULE?

Since Nov 28, 2013, the NADAC for LOTREL 5-10 MG CAPSULE has ranged from a low of $4.8623 (Nov 28, 2013) to a high of $11.5607 (Oct 15, 2025), with a median of $8.4947 per EA.

Are there cheaper alternatives to LOTREL 5-10 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LOTREL 5-10 MG CAPSULE, so no direct lower-cost alternative is listed.

Who manufactures LOTREL 5-10 MG CAPSULE?

LOTREL 5-10 MG CAPSULE (NDC 00078040505) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.